| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66467fe5b0acf469afb972f300bcfb87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c53093bb49e3873fe07b2a0382547084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a82bbac10e8330c18f60e13d24cca638 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 |
| filingDate |
2008-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3a77bb6da0a9818033a5bf1f9490522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd4a5e6cf7e7841c2986737fc74d7bf4 |
| publicationDate |
2013-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8361473-B2 |
| titleOfInvention |
Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases |
| abstract |
Anti CMV antibodies are provided. Thus an antibody of the present invention comprises an antigen recognition domain capable of binding an MHC molecule being complexed with a cytomegalovirus (CMV) pp65 or pp64 peptide, wherein the antibody does not bind said MHC molecule in an absence of said complexed peptide, and wherein the antibody does not bind said peptide in an absence of said MHC molecule. Also provided are methods of using the antibodies. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020033927-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020056047-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018005556-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018005559-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019195491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3992632-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021260186-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019195492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020223535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9346874-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010158927-A1 |
| priorityDate |
2007-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |